US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Prevalence of Target Disorders
5.1.2 Increasing R&D Investments In In-vitro Diagnostics

5.2 Market Opportunities

5.2.1 Technological Advancements in the Field of Fluorescence In Situ Hybridization (FISH) Imaging System

5.3 Future Trends

5.3.1 Increase in the Automation of FISH Technology

5.4 Impact of Drivers and Restraints

6. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Regional Analysis

6.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Overview

6.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue 2020-2030 (US$ Million)

6.3 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Forecast Analysis

7. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Analysis – by Product

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Consumables

7.2.1 Overview
7.2.2 Consumables: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Accessories

7.3.1 Overview
7.3.2 Accessories: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Software

7.4.1 Overview
7.4.2 Software: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2031 (US$ Million)

8. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Analysis – by Application

8.1 Cancer Diagnosis

8.1.1 Overview
8.1.2 Cancer Diagnosis: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Genetic Disease Diagnosis

8.2.1 Overview
8.2.2 Genetic Disease Diagnosis: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Infectious Disease Diagnostic

8.3.1 Overview
8.3.2 Infectious Disease Diagnostic: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

9. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Analysis – by End User

9.1 Diagnostic Laboratories

9.1.1 Overview
9.1.2 Infectious Disease Diagnostic: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Contract Research Organizations

9.2.1 Overview
9.2.2 Infectious Disease Diagnostic: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Pharmaceutical and Biotechnological Companies

9.3.1 Overview
9.3.2 Infectious Disease Diagnostic: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

10. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – United States Analysis

10.1 United States

10.1.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast Analysis – by Country
10.1.1.1 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by Product
10.1.1.1.2 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by Application
10.1.1.1.3 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Euroclone SpA

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 TissueGnostics GmbH

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Agilent Technologies Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Abnova Taiwan Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 BioGenex Laboratories Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Leica Biosystems Nussloch GmbH

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 MetaSystems Probes GmbH

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Bio-View Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Applied Spectral Imaging

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 PerkinElmer Inc

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights